Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

X-linked Hypophosphatemia Disease Monitoring Program (XLH-DMP)

NCT03651505 is registered in ClinicalTrials.gov with Ultragenyx Pharmaceutical Inc as lead sponsor.

NCT NCT03651505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03651505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
X-linked Hypophosphatemia Disease Monitoring Program (XLH-DMP)
Lead sponsor
Ultragenyx Pharmaceutical Inc
Phase
Observational
Overall status
Active, not recruiting
Start date
July 16, 2018
Completion date
December 31, 2032
Enrollment
782 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

hypophosphatemic rickets, x-linked hypophosphatemia